Clinical Trials Directory

Trials / Sponsors / Stallergenes Greer

Stallergenes Greer

Industry · 26 registered clinical trials.

StatusTrialPhaseStarted
CompletedSafety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Ast
Allergic Rhinoconjunctivitis, Birch Pollen Allergy
Phase 32023-09-20
CompletedEvaluation of the Benefits of Sublingual AIT (PRACTIS)
Allergic Rhinitis
2018-08-29
CompletedEfficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-ass
Rhinitis, Allergic, Perennial, House Dust Mite Allergy
Phase 32015-09-29
CompletedObservational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without
Allergy
2014-12-01
TerminatedInternational Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
Allergic Rhinitis Due to Grass Pollens
2014-05-01
CompletedTreatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
Allergy
2013-09-16
CompletedDose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Al
Asthma, House Dust Mite Allergy
Phase 22013-09-01
CompletedSafety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents
Allergic Rhinitis Due to House Dust Mite
Phase 12013-07-01
CompletedSafety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
Asthma, House Dust Mite Allergy
Phase 12012-05-01
CompletedEfficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment
Allergic Rhinitis Due to House Dust Mite
Phase 22010-12-08
CompletedSensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing
Allergy
Phase 32010-12-01
CompletedEfficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen
Hypersensitivity, Allergic Rhinitis, Allergic Conjunctivitis
Phase 32010-11-01
TerminatedSafety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Ado
Allergic Rhinitis Due to Dust Mite
Phase 32009-10-01
CompletedSafety and Tolerability Study of Ragweed SLIT Tablets
Rhinitis, Allergic, Seasonal, Ragweed Pollen Allergy
Phase 12009-01-01
CompletedSafety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivi
Primary Disease
Phase 32009-01-01
CompletedStudy of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic
Allergic Rhinitis Due to Grass Pollens
Phase 32008-10-01
CompletedStudy of rBet v1 Tablets
Birch Pollen-related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal
Phase 22008-10-01
CompletedSafety and Tolerability Study of rBet v1 SLIT Tablets
Birch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal
Phase 12007-11-01
CompletedA Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmat
Allergy
Phase 32007-10-01
CompletedSafety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis
Allergic Rhinitis
Phase 2 / Phase 32007-10-01
CompletedEfficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract
Seasonal Allergic Rhinitis
Phase 12007-09-01
CompletedEfficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen
Allergy
Phase 32006-12-01
CompletedPhase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunother
Allergy
Phase 32006-12-01
CompletedSafety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
Birch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal
Phase 12006-11-01
CompletedSafety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis
Allergy
Phase 2 / Phase 32004-11-01
TerminatedEfficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients
Allergy
Phase 22002-11-01